Jan 16, 2025 | Business, Industry Trends
M&A mania is here. Unprecedented deal values for mergers and acquisitions dominated in 2014. Worldwide M&A was up 47% since 2013 with 95 deals valued greater than $5 billion, as reported by Reuters. Most deals were transacted in the energy,...
Jan 16, 2025 | Case Study, Case Study Forecasting
The Asia-Pacific R&D unit of a large, multinational pharmaceutical company needed a pipeline prioritization approach to guide regional investment and development efforts to maximize continued growth. The portfolio team required a flexible approach that...
Jan 16, 2025 | Business, Chronic Disease, Diabetes, Disease Area Trends
For years, Eli Lilly’s main contributions to the Diabetes market were their insulins: fast-acting analog Humalog® and human insulin Humalin and two premix offerings in analog Humalog® Mix 50/50 and human premix Humalin 75/25. Despite a legacy category, this portfolio...
Jan 16, 2025 | Case Study, Market Scan
A small startup medical device company needed a broader understanding of its potential competitors and a more complete picture of what it would take to succeed, both at launch and over the lifetime of its product. To help pinpoint both opportunities and...
Jan 16, 2025 | Case Study, Case Study Forecasting
When in-house experts’ forecasts for the market potential of a treatment for an orphan disease conflicted, the management team at a large, multinational pharmaceutical company turned to Ozmosi to resolve the differences. Addressing the central questions required a...
